How do I find out if I qualify for a metastatic hormone-sensitive prostate cancer (mhspc) study in Florida?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Florida to take part?

Not necessarily. These studies have a site in Florida, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic hormone-sensitive prostate cancer (mhspc) trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Florida

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) clinical trials in Florida

We’re tracking 3 recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies with a site in Florida — including Phase 1 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Florida

NCT06136650RecruitingPhase 3
Study of a new drug for advanced prostate cancer
This study tests a new oral drug called opevesostat against another standard hormone therapy for men with advanced prostate cancer that has spread and is no longer controlled by a first hormone therapy. It's for men who have not had chemotherapy for this stage and who have not used a PARP inhibitor or chose not to.
Fort Myers, FloridaAges 18 years+
NCT07213674RecruitingPhase 3
A study of xaluritamig plus abiraterone for prostate cancer
This trial tests a new combination of two drugs (xaluritamig plus abiraterone) for men with a type of advanced prostate cancer that is no longer responding to hormone therapy but has not yet been treated with chemotherapy. The goal is to see if this combination works better than the standard options your doctor might choose.
Tampa, FloridaAges 18 years+
NCT05818683RecruitingPhase 1
Pasritamig plus other drugs for advanced prostate cancer
This Phase 1 study tests pasritamig (JNJ-78278343) combined with other prostate cancer treatments in people with advanced prostate cancer that has spread. It aims to find the safest dose and see whether the combinations can help slow the cancer.
Sarasota, FloridaAges 18 years+

Where these studies are running in Florida

Institutions with a site for the recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies listed above.

Florida Cancer Specialists & Research Institute · 2 studies
H. Lee Moffitt Cancer Center and Research Institute
Memorial Hospital West
Mount Sinai Medical Center

What taking part in a metastatic hormone-sensitive prostate cancer (mhspc) study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials in other states

Common questions

Are there metastatic hormone-sensitive prostate cancer (mhspc) clinical trials in Florida?: Yes. We're currently tracking 3 recruiting metastatic hormone-sensitive prostate cancer (mhspc) studies with a site in Florida, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic hormone-sensitive prostate cancer (mhspc) study in Florida?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Florida to take part?: Not necessarily. These studies have a site in Florida, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic hormone-sensitive prostate cancer (mhspc) trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic hormone-sensitive prostate cancer (mhspc) studies open in Florida regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.